- World rank, all time
- #18,749 of 42,892
- Rank in Australia
- #348 of 656
- Research works
- 193 ▲ 16% vs 2013–17
- Citations
- 7.6k 39.6 per fractional work
- Top-10% rate
- 23.5% record average 16.5%
- Open access
- 61% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.4×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 4.4×
- Immunology and Microbiology 3.7×
- Medicine 3.3×
- Nursing 1.9×
- Chemistry 1.0×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Economics, Econometrics and Finance 0.4×
- Neuroscience 0.3×
- Physics and Astronomy 0.2×
- Health Professions 0.2×
- Materials Science 0.1×
- Dentistry 0.1×
- Computer Science 0.1×
- Engineering 0.1×
- Environmental Science 0.1×
- Mathematics 0.1×
- Agricultural and Biological Sciences 0.1×
- Psychology 0.1×
- Social Sciences 0.0×
- Decision Sciences 0.0×
Which keywords describe research at The Kinghorn Cancer Centre?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Microenvironment, Chemotherapy, Genetic Mutations, Clinical Trials, Targeted Therapy, Cancer and Biomarkers.
- Survival Analysis
- Drug Resistance
- Radioimmunotherapy
- Dosimetry
- Metastasis
- Surgical Complications
- Cancer Treatment
- Immune Checkpoint Blockade
- Cancer Immunotherapy
- Mutational Signatures
- Radiation Therapy
- Metastatic Prostate Cancer
- Radiotherapy
- Neoadjuvant Therapy
- Hormone Therapy
- Cancer Therapy
- Biomarkers
- Clinical Trials
- Genetic Mutations
- Tumor Microenvironment
- Immunotherapy
- Chemotherapy
- Cancer
- Targeted Therapy
- Prostate Cancer
- Genomic Profiling
- Gene Expression
- Prognostic Factors
- Androgen Receptor
- Genomic Instability
- Cancer Genomics
- PET Imaging
- Pancreatic Cancer
- PD-1 and PD-L1
- Gemcitabine
- Breast Cancer
- Clinical Guidelines
- Molecular Classification
- Radiopharmaceuticals
- Genetic Variants
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy9▲ 22×15 topics
- Tumor Microenvironment5▲ 21×8 topics
- Chemotherapy5▲ 13×19 topics
- Genetic Mutations5▲ 20×10 topics
- Cancer5▲ 6.2×29 topics
- Clinical Trials5▲ 12×10 topics
- Targeted Therapy5▲ 37×5 topics
- Biomarkers4▲ 9.9×8 topics
- Prostate Cancer4▲ 50×4 topics
- Cancer Therapy3▲ 8.8×13 topics
- Genomic Profiling3▲ 49×2 topics
- Hormone Therapy3▲ 60×3 topics
- Gene Expression3▲ 7.5×9 topics
- Neoadjuvant Therapy2▲ 19×5 topics
- Prognostic Factors2▲ 10×14 topics
- Radiotherapy2▲ 12×9 topics
- Androgen Receptor2▲ 58×1 topic
- Metastatic Prostate Cancer2▲ 104×1 topic
- Genomic Instability2▲ 37×2 topics
- Radiation Therapy2▲ 30×5 topics
- Cancer Genomics2▲ 51×1 topic
- Mutational Signatures2▲ 51×1 topic
- PET Imaging2▲ 22×4 topics
- Cancer Immunotherapy2▲ 23×3 topics
- Pancreatic Cancer2▲ 32×2 topics
- Immune Checkpoint Blockade2▲ 31×1 topic
- PD-1 and PD-L12▲ 31×1 topic
- Cancer Treatment2▲ 13×5 topics
- Gemcitabine2▲ 44×1 topic
- Surgical Complications2▲ 39×1 topic
- Breast Cancer2▲ 12×10 topics
- Metastasis2▲ 8.2×10 topics
- Clinical Guidelines2▲ 9.0×4 topics
- Dosimetry2▲ 39×2 topics
- Molecular Classification2▲ 17×4 topics
- Radioimmunotherapy2▲ 94×1 topic
- Radiopharmaceuticals2▲ 94×1 topic
- Drug Resistance1▲ 8.6×3 topics
- Genetic Variants1▲ 15×4 topics
- Survival Analysis1▲ 9.4×5 topics
Which research topics does The Kinghorn Cancer Centre publish most on?
By volume in 2022–2025: Prostate Cancer Treatment and Research, Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers and Pancreatic and Hepatic Oncology Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works
- 2 Cancer Genomics and Diagnostics Cancer Research 2 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 4 Pancreatic and Hepatic Oncology Research Oncology 2 works
- 5 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
- 6 Cancer Cells and Metastasis Oncology 1 works
- 7 Prostate Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works
- 8 Single-cell and spatial transcriptomics Molecular Biology 1 works
- 9 Ocular Oncology and Treatments Ophthalmology 1 works
- 10 CAR-T cell therapy research Oncology 1 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has The Kinghorn Cancer Centre's research output changed?
Output in 2018–2022 was 16% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Sydney
- The University of Sydney
- UNSW Sydney
- Macquarie University
- University of Technology Sydney
- Royal Prince Alfred Hospital
- Westmead Hospital
- Prince of Wales Hospital
- Children's Hospital at Westmead
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.